Live Breaking News & Updates on Gazyvaro Gazyva

Stay updated with breaking news from Gazyvaro gazyva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

F. Hoffmann-La Roche Ltd: FDA accepts supplemental Biologics License Application for Roche's Polivy combination for people with previously untreated diffuse large B-cell lymphoma

First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphoma Application is based on pivotal data from the phase III POLARIX study ....

United States , Gazyvaro Gazyva , Mabthera Rituxan , Sabine Borngr , Gerard Tobin , Bruno Eschli , Venclexta Venclyxto , Birgit Masjost , Sileia Urech , Loren Kalm , Karsten Kleine , Nathalie Altermatt , Lymphoma Study Association , Roche Group , Roche Group Media Relations , Lymphoma Academic Research Organisation , Lugano Response Criteria , Dow Jones Sustainability Indices , Chugai Pharmaceutical ,